Trivium Point Advisory, LLC - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 53 filers reported holding ENZO BIOCHEM INC in Q4 2022. The put-call ratio across all filers is 4.60 and the average weighting 0.3%.

Quarter-by-quarter ownership
Trivium Point Advisory, LLC ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q1 2024$24,765
-8.6%
19,5000.0%0.01%
-28.6%
Q4 2023$27,105
+3.0%
19,5000.0%0.01%0.0%
Q3 2023$26,325
-26.6%
19,5000.0%0.01%
-30.0%
Q2 2023$35,880
-24.3%
19,5000.0%0.01%
-23.1%
Q1 2023$47,385
+83.0%
19,500
+5.4%
0.01%
+62.5%
Q4 2022$25,900
-36.8%
18,500
+2.8%
0.01%
-38.5%
Q3 2022$41,000
+5.1%
18,0000.0%0.01%
+8.3%
Q2 2022$39,000
-26.4%
18,0000.0%0.01%0.0%
Q1 2022$53,000
-8.6%
18,0000.0%0.01%0.0%
Q4 2021$58,000
-17.1%
18,0000.0%0.01%
-29.4%
Q3 2021$70,000
+22.8%
18,0000.0%0.02%
+21.4%
Q2 2021$57,000
-8.1%
18,0000.0%0.01%
-17.6%
Q1 2021$62,000
+29.2%
18,0000.0%0.02%
+21.4%
Q4 2020$48,000
+26.3%
18,0000.0%0.01%
+7.7%
Q3 2020$38,000
-11.6%
18,000
+2.3%
0.01%
-23.5%
Q2 2020$43,000
+2.4%
17,6000.0%0.02%
-22.7%
Q1 2020$42,000
-6.7%
17,600
+2.5%
0.02%
+29.4%
Q4 2019$45,000
-25.0%
17,1750.0%0.02%
-39.3%
Q3 2019$60,000
+3.4%
17,1750.0%0.03%
+7.7%
Q2 2019$58,000
+23.4%
17,1750.0%0.03%
+18.2%
Q1 2019$47,000
-2.1%
17,1750.0%0.02%
-24.1%
Q4 2018$48,00017,1750.03%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 1,105,139$3,072,0006.35%
HARBERT FUND ADVISORS, INC. 1,605,000$4,461,0004.55%
Evermore Global Advisors, LLC 4,527,819$12,587,0002.06%
CORRADO ADVISORS, LLC 223,783$622,0000.61%
MARATHON CAPITAL MANAGEMENT 332,046$923,0000.46%
KEMPNER CAPITAL MANAGEMENT INC. 95,476$265,0000.18%
Alambic Investment Management, L.P. 41,097$114,0000.05%
ALGERT GLOBAL LLC 58,171$162,0000.04%
Trivium Point Advisory, LLC 17,175$48,0000.03%
GSA CAPITAL PARTNERS LLP 61,657$171,0000.02%
View complete list of ENZO BIOCHEM INC shareholders